The Scotts Miracle
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 28 in the most recent period (2026/Q3).
- Total institutional ownership rose 4.3 percentage points.
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 115.44% +4.34pp
- Institutions
- 495 -28
- As of
- 2026/Q3 vs. prior period
Holder types
Top holders as of 2026-08-03
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 43 buys · 7 sells
| Name | Role | Stake |
|---|---|---|
| Hagedorn Partnership LP | -- | 22.57% |
| Nathan Baxter | Chief Executive Officer | 0.18% |
| James Hagedorn | Former Chairperson & CEO | 0.13% |
| Christopher Hagedorn | Chief Strategy Officer | 0.10% |
| Adam Hanft | Former Director | 0.08% |
| Stephen Johnson | Independent Director | 0.05% |
| Dimiter Todorov | Executive Vice President | 0.05% |
| David Evans | Independent Director | 0.04% |
| Nick Miaritis | Executive VP & Chief Brand Officer | 0.04% |
| Peter Shumlin | Independent Chairperson | 0.04% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-12 | Peter Shumlin | Independent Chairperson | Intent to Sell (Form 144) | -3,716 | $64.51 |
| 2026-11-08 | David Evans | Independent Director | Open Market Disposition | -2,655 | $66.42 |
| 2026-10-29 | Mark Scheiwer | Chief Financial Officer | Other Acquisition | +3 | $46.85 |
| 2026-10-27 | Dimiter Todorov | Executive Vice President | Other Acquisition | +9,947 | -- |
| 2026-10-27 | Mark Scheiwer | Chief Financial Officer | Other Acquisition | +2,163 | -- |
| 2026-10-27 | Nathan Baxter | Chief Executive Officer | Other Acquisition | +23,872 | -- |
| 2026-10-25 | Mark Scheiwer | Chief Financial Officer | Other Derivative Acquisition | +12 | -- |
| 2026-10-01 | Mark Scheiwer | Chief Financial Officer | Sale to Issuer | -1,559 | $49.02 |
| 2026-10-01 | Mark Scheiwer | Chief Financial Officer | Derivative Exercise and Retained | +500 | -- |
| 2026-09-30 | Stephen Johnson | Independent Director | Other Acquisition | +144 | -- |
| 2026-09-30 | Brian Sandoval | Independent Director | Other Acquisition | +575 | -- |
| 2026-09-29 | Mark Scheiwer | Chief Financial Officer | Other Acquisition | +3 | $45.88 |
| 2026-09-27 | Mark Scheiwer | Chief Financial Officer | Other Derivative Acquisition | +14 | -- |
| 2026-09-04 | Nathan Baxter | Chief Executive Officer | Sale to Issuer | -12,023 | $57.53 |
| 2026-09-03 | Mark Kingdon | Independent Director | Other Derivative Acquisition | +118 | -- |
| 2026-09-03 | Katherine Littlefield | Vice-Chairman of the Board | Other Derivative Acquisition | +37 | -- |
| 2026-09-03 | Adam Hanft | Former Director | Other Derivative Acquisition | +118 | -- |
| 2026-09-03 | Stephen Johnson | Independent Director | Other Derivative Acquisition | +155 | -- |
| 2026-09-03 | David Evans | Independent Director | Other Derivative Acquisition | +118 | -- |
| 2026-09-03 | Brian Sandoval | Independent Director | Other Derivative Acquisition | +179 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
The Scotts Miracle discussion 0 comments